Location
: Barcelona - Spain (3 days working from the office and 2 days working from home)
At
Alexion, AstraZeneca Rare Disease
, this role offers the opportunity to shape access for transformative medicines in areas of high unmet need and make a meaningful impact for patients living with
rare neurological diseases
. You will operate in a highly visible, strategic position with broad cross-functional exposure, leading portfolio-level market access, pricing, and reimbursement strategy across key markets, with a particular focus on the
NMOSD
indication. This is an opportunity for an experienced market access leader to influence critical launch and lifecycle decisions, navigate complex payer environments, and play a central role in advancing our ambition within
Neurology
.
What
you'll
will
do:
Join a highly valued, strategic team that is fundamental to realizing the potential of our life-changing medicines. Through our work, AstraZeneca
is able to
ensure that appropriate access is provided to our transformative therapies.
Alexion, AstraZeneca Rare Disease's
Global Value Access and Pricing (
GVAP
) team is seeking a qualified
Director
to join a dynamic and growing team, with responsibility for
Neurology
indications, including near-term new product launches and label expansions.
As a key member of the
GVAP
team, you will help shape and execute global value, access, and pricing strategies across the
Neurology portfolio
in selected key EU markets
, with
particular strategic
focus on the
NMOSD indication
and its lifecycle management
This is a strategic role that leverages your understanding and application of global healthcare and health technology assessment (
HTA
) systems, competitive insights, and clinical knowledge to shape market access, pricing, and reimbursement success for critical product launches and indications.
The ideal candidate for this role will have deep expertise in global payer,
HTA
, and reimbursement ecosystems, with a strong track record of driving market access, pricing, and reimbursement success within
rare diseases and Neurology
.
You will be responsible for:
Value
Lead and drive cross-functional development of a clear, differentiated value proposition for
NMOSD
, while influencing without authority and navigating complex organizational systems.
Collaborate with cross-functional teams to ensure that evidence generation plans and real-world evidence (
RWE
) are incorporated effectively to deliver a comprehensive value proposition, reduce uncertainty for payers, and optimize patient access. This includes securing timely country input on endpoints and evidence generation plans in priority target countries.
Provide support to the
GMMA Commercial
team to advance
NMOSD lifecycle management (LCM)
through governance milestones focused on market access potential, evidence, and




target product profile (TPP)
requirements.
Access
Lead
development of
general market access and pricing strategies
-
activities
and
support implementation
in close partnership with country access representatives
of
assigned countries
Lead the assessment of pricing and reimbursement (
P&R;
) risks and opportunities, and the implementation of corresponding mitigation actions specific to
Neurology
.
Create and roll out strategic value, access, and pricing communication tools and materials for
NMOSD
to support local
P&R;
submissions and negotiations, such as pricing frameworks, negotiation strategies, and toolkits, in alignment with the enterprise-wide launch framework.
Lead the update of the global reimbursement dossier for
NMOSD
and the overall cross-functional market access readiness plans for
Neurology
, in close collaboration with key countries and support functions (
HEOR, Medical, and Commercial
).
Represent the
GVAP
perspective and strategy across various cross-functional teams, including the
Global Value Sub-Team
and
Global Launch Team
, and provide updates and guidance to local teams as needed.
Own the monthly
Neurology
payer working group to share the latest evidence and drive best practice sharing across countries.
Understand and incorporate the
patient
perspective on the
disease, and
recommend strategies that support the
patient
voice in key payer negotiations.
Pricing
Support the development of
the
Neurology
pricing strategy.
Conduct payer and value assessments to identify key market-specific P&R; drivers and barriers, develop differentiated value propositions, and inform evidence generation plans, regulatory strategy, and development decisions.
For the top EU Neurology markets, lead and co-create market-level P&R; strategies and support P&R; submissions and negotiations to drive positive outcomes.
Review P&R; cases submitted by
markets, and
support markets in maintaining value while unlocking local access
working i
n close partnership with country access representatives and /or access International shared markets
GVAP
team for relevant countries.
Offer critical strategic input to inform access and pricing assumptions, enabling accurate, market-driven LTP assumptions.
Communicate effectively with GMMA senior leadership and other key stakeholders, particularly in relation to
Neurology launches and NMOSD LCM P&R; strategy.
You will need to have:
Demonstrate
d




leadership and
the
ability to take initiative and consistently deliver high-quality work
in the context of rare
diseases evidence
, where there is greater
uncertainty and
competiiton
.
The ability
to
c
ommunicate effectively
and transla
te
science into compelling
payer value story benefits
for
Alexion
leadership and other identified stakeholders
,
including close collaboration
with
local market access colleagues and the Commercial Launch Excellence function.
Experience
developing
evidence-based innovative value solutions,
for example
through working with local payers in
the
EU or commercial customers in the US.
A r
elevant
g
raduate degree
, such as a
PhD, PharmD,
B
iomedical
S
cience
s
, business, or economics
qualification.
Highly specialized rare disease
and
/
or N
eurology
market access experience
.
More than 6 years of r
elevant drug development and/or commercialization experience within the pharmaceutical/medical industry
.
Knowledge of the needs and expectations of national and regional payers, insurers, and commercial customers in our strategic markets
.
Knowledge and experience in key
cost-effectiveness
markets
, such as the
UK, Canada and
the
Nordics
,
is preferred.
The duties of this role are generally conducted in an office environment. As is typical of an office-based role, employees must be able, with or without accommodation
,
to
use a computer; engage in communications via phone, video, and electronic messaging; engage in problem
-
solving and non-linear thought, analysis, and dialogue; collaborate with others; maintain general availability during standard business hours.
Date Posted
17-jun-****
Closing Date
31-jul-****
Alexion is proud to be an Equal Employment Opportunity and Affirmative Action employer. We are committed to fostering a culture of belonging where every single person can belong because of their uniqueness. The Company will not make decisions about employment, training, compensation, promotion, and other terms and conditions of employment based on race, color, religion, creed or lack thereof, sex,
sexual orientation,
age, ancestry, national origin, ethnicity, citizenship status, marital
status, pregnancy,
(including childbirth, breastfeeding, or related medical conditions), parental status (including adoption or surrogacy), military status, protected veteran status, disability, medical condition, gender identity or expression, genetic information, mental illness or other characteristics protected by law. Alexion provides reasonable accommodations to meet the needs of candidates and employees. To begin an interactive dialogue with Alexion regarding an accommodation, please contact
******
. Alexion participates in E-Verify.

📌 Global Pricing & Access Lead, Rare Neurology (Laza)
🏢 Alexion Pharmaceuticals,Inc.
📍 Laza